In the US, shares of ImClone Systems were gaining ground in pre-market dealings this morning after the biotech firm said its early-stage cancer therapy research is yielding encouraging results.

Wall Street managed a sharp rebound today, rising sharply despite allegations of insider trading at ImClone and more profit warnings.